News tagged with oxaliplatin
Scientist proves potential of new nanoparticle design for cancer therapy
A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor ...
Nanotechnology / Bio & Medicine
Sep 20, 2011 |
5 / 5 (2) |
0
A safe, well-tolerated, and effective treatment for metastatic esophageal cancer
Metastatic esophageal squamous cell cancer has very poor prognosis. Conventional surgery is considered the most effective treatment, but many cases are inoperable at the time of diagnosis.
Feb 23, 2009 |
5 / 5 (1) |
0
Chemotherapy combination outcomes differ for aged, younger colon cancer patients
ORLANDO, Fla.--The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 -- but not for ...
May 29, 2009 |
5 / 5 (1) |
0
Costly cancer drugs are worth it, study finds
(PhysOrg.com) -- The cost for chemotherapy medications to treat colorectal cancer for six months has jumped 2,600 percent from 1993 to 2005. But such rising costs are worth the price, asserts a new report from Cornell, when ...
Aug 14, 2009 |
2.5 / 5 (2) |
2
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug ...
Sep 24, 2009 |
4 / 5 (1) |
0
Cetuximab did not add significant benefit to NORDIC FLOX regimen in first line treatment of mCRC
Adding the targeted drug cetuximab to a three-drug chemotherapy regimen for first-line treatment of metastatic colorectal cancer does not improve response rate, progression-free survival or overall survival, researchers reported ...
Oct 12, 2010 |
4 / 5 (1) |
0
Oxaliplatin
Oxaliplatin is a coordination complex that is used in cancer chemotherapy. These platinum-based drugs are usually classified as alkylating agents, although they are not actually alkylating groups (they function by a similar mechanism).
For more information about Oxaliplatin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
